FDA — authorised 4 September 1958
- Application: NDA011145
- Marketing authorisation holder: RISING
- Local brand name: DIURIL
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised Chlorothiazide Injection on 4 September 1958
Yes. FDA authorised it on 4 September 1958; FDA authorised it on 6 October 1961.
RISING holds the US marketing authorisation.